Ad
related to: john carreyrou theranos article pdf free
Search results
Results From The WOW.Com Content Network
In late 2015, Carreyrou began a series of investigative articles on Theranos, published in The Wall Street Journal on the blood-testing startup founded by Elizabeth Holmes. The articles questioned the company's claim to be able to run a wide range of lab tests from a tiny sample of blood from a finger prick.
John Carreyrou (/ ˌ k ær i ˈ r uː /) [1] is a French-American investigative reporter at The New York Times. Carreyrou worked for The Wall Street Journal for 20 years between 1999 and 2019 [ 2 ] and has been based in Brussels , Paris , and New York City .
Specifically, he was a crucial source for The Wall Street Journal where John Carreyrou would report on Theranos for several years. In 2017, Shultz was named to Forbes ' 30 Under 30 for Healthcare. Forbes stated that Shultz, aged 26 at the time, "shaped the year's biggest healthcare story" as a Theranos whistleblower while also crediting his ...
In the Wall Street Journal investigative reporter John Carreyrou's new book, "Bad Blood: Secrets and Lies in a Silicon Valley Startup," he describes a demonstration of the technology in 2006 in ...
John Carreyrou, the former Wall Street Journal reporter whose dogged reporting uncovered the Theranos scam, has weighed in after Elizabeth Holmes reported for prison to begin her 11-year sentence ...
Theranos Inc. (/ ˈ θ ɛr. ə n. oʊ s /) was an American privately held corporation [5] that was touted as a breakthrough health technology company. Founded in 2003 by then 19-year-old Elizabeth Holmes, Theranos raised more than US$700 million from venture capitalists and private investors, resulting in a $9 billion valuation at its peak in 2013 and 2014.
For premium support please call: 800-290-4726 more ways to reach us more ways to reach us
Ken Auletta, a journalist with The New Yorker who wrote an article on Holmes in 2014. John Carreyrou, a journalist with The Wall Street Journal who read Auletta's work in The New Yorker, investigated Theranos's practices and wrote the influential article that accused Theranos of massive misrepresentation of what their company was offering, and ...